Evidence map›Paper›PMID 31768925›Full record

ReviewJournal of echocardiography2020

New horizon of fusion imaging using echocardiography: its progress in the diagnosis and treatment of cardiovascular disease.

Yoichi Takaya, Hiroshi Ito

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of echocardiography, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yoichi TakayaDepartment of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. takayayoichi@okayama-u.ac.jp.
Hiroshi ItoDepartment of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac imaging modalities are essential for the management of cardiac diseases. Multimodality imaging, such as echocardiography, cardiac computed tomography (CT), cardiac magnetic resonance imaging, and fluoroscopy, is required for assessing cardiac condition. In recent years, fusion imaging, which integrates different imaging modalities on the same screen, has been developed. Because the fusion imaging is able to merge the advantages of each modality, it has the potential to be valuable for accurate diagnosis as well as the planning of therapeutic strategies. In the clinical setting, the fusion imaging of real-time transthoracic echocardiography with cardiac CT displayed side by side has reportedly been effective for the diagnosis and the assessment of disease severity in patients with adult congenital heart disease. The overlay of real-time three-dimensional transesophageal echocardiography onto fluoroscopy, which is dynamic fusion imaging, has been used for structural heart disease interventions. The fusion imaging has become increasingly important in the field of cardiac diseases. This review discusses the benefits of echocardiographic fusion imaging.

Indexed as

EchocardiographyFluoroscopyTomography, X-Ray ComputedAdultCoronary Artery DiseaseHeart Defects, CongenitalHumansImaging, Three-DimensionalMultimodal ImagingAdult congenital heart diseaseCoronary artery diseaseEchocardiographyFusion imagingStructural heart disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.